Rivastigmine hydrogen tartrate (RT) is a molecule with both hydrophilic and hydrophobic
properties used for the treatment of the Alzheimer's disease. In this work, the larger pore size …

Targeted delivery of neurological therapeutic to the brain has been attracting more and more
attention to the treatment of central nervous system (CNS) diseases. Nonetheless, the main …

The present study was aimed at delivering a low bioavailability drug, rivastigmine hydrogen
tartrate (RTG), to the brain through its encapsulation in mesoporous silica nanoparticles …

The rivastigmine (RHT) loaded chitosan nanoparticles (CS-RHT NPs) were prepared by
ionic gelation method to improve the bioavailability and enhance the uptake of RHT to the …

Recent studies with inorganic nanoparticles modified with functional groups have
demonstrated improvement in drug delivery into cancer cells. In the present study, we …

Herein, three kinds of mesoporous silica nanoparticles (BMSs) were biomimetically
synthesized by using heterocyclic amino acid derivatives as template and their the basic …

Herein, we present development of new pH-responsive drug delivery systems for D3-
dopamine receptor agonist pramipexole, based on its encapsulation in MCM-41 …

Background To sustain the effect of rivastigmine, a hydrophilic cholinesterase inhibitor,
nanobased formulations were prepared. The efficacy of the prepared rivastigmine liposomes …

Mesoporous silica nanoparticles with a hexagonal structure (SBA-15) were synthesized and
modified with (3-aminopropyl) triethoxysilane (APTES), and their performance as a carrier …

In this study, spherical hollow mesoporous silica (HMS) particles with average size of 550
nm were loaded with dopamine-receptor agonist pramipexole, as a model drug. High drug …